|
Chronology of Dr. Nemechek’s Harassment by Medicare
The Beginning Medicare decides to target Dr. Nemechek, and
has Medical Director change immune globulin guidelines to ‘nab as
corrective action’ against Dr. Nemechek. This action occurred
prior to Medicare reviewing Dr. Nemechek's medical records
concerning his use of immune globulin.
August 1999 Medicare issues first audit letter
questioning Dr. Nemechek’s use of immune globulin in the treatment of
antibody deficiency secondary to HIV infection.
January 2000 Medicare claims Dr. Nemechek’s use of immune
globulin was not according to Medicare guidelines and demands repayment
of $168,783.
May 2000 Medicare appeals process
determines "the patients medical
condition's met coverage specifications defined in the carrier's LMRP
[treatment guidelines] and, as such, Dr. Nemechek was appropriately
reimbursed for his care."
July 2000 Medical Director for local Medicare
carrier affirms in a letter to Dr.
Nemechek that as long he was treating the patient’s antibody
deficiency state and not directly treating HIV with antibody
transfusions, that reimbursement would not be denied.
August 2001 Medicare audits Dr. Nemechek again for the
use of immune globulin in the treatment of antibody deficiency secondary
to HIV infections; many of the patients records examined had previously
been determined to qualify for coverage by Medicare in the first audit.
January 2002 Medicare claims Dr. Nemechek’s use of immune
globulin was not according to Medicare guidelines and demands repayment
of $167,192.
September 2002 Once again, Medicare appeals process
determines Dr. Nemechek’s medical
care was ‘appropriate and necessary’ and reverses repayment demand for
immune globulin.
August 2004 Medicare sends Dr. Nemechek a letter
informing him of new rules (Medical
Review) which effectively eliminate reimbursement of immune globulin
for patients with antibody deficiency secondary to HIV infection.
August 2004 Dr. Nemechek seeks help from regional
Medicare office about Medicare carrier’s ongoing effort to prevent him
from treating his HIV patients with immune globulin. Informs officials
he is being set up for another audit.
August 2004 Dr. Nemechek receives his third audit letter
for the use of immune globulin in persons infected with HIV.
Note: During all three audits, only patients
with HIV are audit. None of Dr. Nemechek’s HIV negative patients
receiving the same treatment were ever audited by Medicare.
September 1, 2004 Because of new rules issued in Medical Review,
Dr. Nemechek’s no longer can receive immune globulin because lack of
reimbursement.
September, 2004 Attorneys for Dr. Nemechek issue ‘demand
letter’ to Medicare carrier.
September 2004 Washington Congressional Representatives Moore,
McCarthy and Ryun initiate inquires about Medicare’s persistent
harassment of Dr. Nemechek and his HIV-infected patients.
October 2004 Patient admitted to hospital because infection
after having immune globulin therapy discontinued because payment by
Medicare is discontinued.
October 6, 2004 Dr.
Nemechek holds town hall meeting giving patients, family and friends
overview of Medicare harassment. See
PowerPoint presentation
for details.
October 2004 Dr. Nemechek is encouraged by support from
Congressional Representatives now including Senator’s Brownback,
Roberts, Talent and Bond.
October 13, 2004 Dr. Nemechek legal
counsel send off Freedom of
Information Act (FOIA) petitions seeking information concerning
information relevant to immune globulin regulations, HIV Disease and Dr.
Nemechek in particular.
October 2004 Medicare issues
new proposal (LCD)
to permanently prevent patients with HIV from ever receiving immune
globulin for antibody deficiency.
November 2004
Several FOIA petitions are rejected.
December 2004 Patient develops pneumonia after having immune
globulin reimbursement discontinued. Majority of patient's who've
had their immune globulin discontinued have had a drastic worsening of
their fatigue, return of their drenching night sweats, and repeated
sinusitis or bronchitis.
December 1, 2004 Dr. Nemechek meets with Medicare carrier
representatives and Kansas City Medicare officials. Carrier
representatives admit they were “upset” their audits of me were
overturned and that my medical care was found to be necessary and
appropriate. They even admit they continued to audit Dr. Nemechek in
spite of knowing his medical care had been determined to be appropriate
in each prior audit.
December 4, 2004 Dr. Nemechek receives phone call from aide to
Senate Majority Leader (and former cardiac transplant Surgeon), Senator
Bill Frist. Senator Frist is reported to be upset about the harassment
Dr. Nemechek and his patients are receiving at the hands of local
Medicare carrier. Senator Frist's office has recommended Senator Grassley
(Senate Finance Committee Chairman) to have the issue investigated by
Subcommittee on Medicare Operations and Investigations.
January 10, 2005 Dr. Nemechek delivers
lengthy critique of proposed LCD during
comment period. Critique includes letters from two researchers whose
scientific research was used by Medicare to support their restriction of
use immune globulin in patients with HIV. Both researchers wrote that
their work was misrepresented, and believe patients with antibody
deficiency secondary to HIV should be treated with immune globulin if
clinically warranted.
January 20, 2005
Appeals to previous FOIA denials are
sent out.
January 26, 2005 Senators Frist's office is still
pursuing harassment issue through both CMS (Medicare) and the Senate
Finance Committee Investigative Staff.
January 26, 2005 Local
American Civil Liberties Union (ACLU) official meets with Dr. Nemechek
and agrees that the facts seem to point to repeated targeting of persons
with HIV Disease. Official will present material to ACLU office in
Washington, D.C. that specializes in HIV and AIDS-related issues.
January 27, 2005
Attorney's for Dr. Nemechek receive phone call from senior Medicare
employee stating that the prior FOIA denials were inaccurate and that
the documents from those organizations would be forth coming.
January 28, 2005 Senators
Brownback and Talent's legislative staff believe there is no legislative
remedy for present issue. Medicare is keeping them at bay by
constantly framing this as a medical decision issue which the
legislators have no authority in rather than being willing to respond
the the charges of harassment of physicians and targeting of HIV
patients. Legislators are waiting for conclusion of Senate
Finance Committee investigation
January 31, 2005 Dr. Nemechek receives
threatening phone call from Beth Gebielhaus, National Program Director
for Medical Review, Medicare. After complaining that he feels like a target, Dr. Nemechek is
told that "he is a target". Official states that
treatment of HIV patients with immune globulin is completely
inappropriate. She states that immune globulin is the "most abused
medication in the country" because doctors give it only to make money. Official angrily tells Dr. Nemechek
that his HIV patients don't deserve to receive immune globulin therapy in
spite of the fact that upon appeal, other Medicare officials declared
that his past use of immune globulin was "medically appropriate". After
hearing this, she implied that she was going to call the office that
supported the use of immune globulin in patients with HIV and put a stop
to their support.
February 1, 2005 Another patient who has
has been deprived immune globulin from recent Medicare rule change
develops bacterial pneumonia.
February 2, 2005 Dr. Nemechek
responds in
writing to the threats he received from Medicare official on February 1,
2005.
February 2, 2005 Another patient informs
Dr. Nemechek he is moving to another part of the country where a
different set of Medicare regulations would allow him to continue
receiving immune globulin.
February 9, 2005 A
summary of
comments submitted to Medicare concerning proposed their proposed
IVIG LCD is posted on Kansas Medicare website. Medicare fails to
mention that both scientists whose work was used to provide the
scientific foundation for their dangerously restrictive rules submitted
letters against Medicare's position that no persons shall receive
off-label immune globulin for secondary immune deficiency.
Additionally there is no mention of Medicare's complete failure to
follow appropriate procedures in developing this LCD.
February
17, 2005 Senator Bond's office is
initiating a legislative inquiry through the central CMS office.
Dr. Nemechek submits documentation
and proposed questions to be addressed by CMS.
February 23, 2005 Another patient who has has been deprived immune
globulin from recent Medicare rule change develops bacterial pneumonia.
February 24, 2005 A patient who has has been deprived immune
globulin from recent Medicare rule change continues to loose weight
since being discontinued from immune globulin with total weight lose of
43 lbs to date.
February 24, 2005 Senator Christopher (Kit) Bond sends Mark
McClellen, Director, Department of Health and Human Services, a
letter
requesting him to review repeated harassment of Dr. Nemechek and his
patients.
March 1, 2005
Patient who was previously receiving immune globulin through his private
health insurance has now change to Medicare as his primary form of
health insurance because of his continuing disability. He will no
longer will be able to receive treatment with immune globulin because
Medicare's restrictive new policy of immune globulin does not allow what
was considered medically appropriate by the patients private medical
insurance.
April 1, 2005
The new region guidelines
for IVIG become active. In spite of the numerous scientific and
procedural flaws outlined in
comments
submitted by Dr. Nemechek during the open comment period, proposed
guidelines are published intact without any changes making them the most
restrictive guidelines for the use of immune globulin in
immunodeficiency in the entire United States.
June 20, 2005 Four
patients who have been denied access to IVIG because of Medicare's new
regulations file
a petition in court to have the new regulations reviewed by an
Administrative Law Judge.
September, 2005 After a few
delaying tactics, Medicare finally submits it response to the patients'
petition to the ALJ court.
March , 2006
The Administrative Law Judge finally
submits his ruling in favor of Medicare without even holding a
hearing to discuss this life-threatening issue.
April 13, 2006
Patients quickly file an
appeal of the judges ruling to a special committee in Washington,
D.C.. This summarily denied.
September 2007
Patients quickly file a petition and brief to the U.S Federal Court in Missouri.
June 30, 2008
The U.S. Federal Judge issues a brief judgement in favor of Medicare. The Patient's attorney's find the Judge's Order brief and unacceptable and recommend the case be appealed to the U.S. Federal Court of Appeals.
July 16, 2008
Patients agree to go forward with an appeal the the U.S. Federal Court of Appeals in hopes that one of the 3 judges will look at the broad scope of Medicare's strong-handed and determined efforts to prevent patient's with HIV from receiving IVIG.
|